Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated

International Journal of Pharmaceutics

Volumn 349, Issue 1-2, 2008, Pages 66-73

  de Waard, H ^a   Hinrichs, W L J ^a   Visser, M R ^a   Bologna, C ^a   Frijlink, H W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Crystallization; High drug load; Poorly soluble drug; Sodium lauryl sulphate; Sugar glass

Indexed keywords

DIAZEPAM; DODECYL SULFATE SODIUM; FENOFIBRATE; GLASS; HD 0391111; INULIN; SUGAR; TREHALOSE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DRUG DISTRIBUTION; DRUG MIXTURE; DRUG SOLUBILITY; DRUG SYNTHESIS; FREEZE DRYING; PRIORITY JOURNAL; TABLET FORMULATION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHYSICAL; CRYOPRESERVATION; CRYSTALLIZATION; DIAZEPAM; DRUG COMPOUNDING; INDICATORS AND REAGENTS; INSULIN; PROCETOFEN; SODIUM DODECYL SULFATE; SOLUBILITY; SURFACE-ACTIVE AGENTS; TABLETS; TREHALOSE;

EID: 37349024249     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.07.023     Document Type: Article

References (33)

1. Alden M., Tegenfeldt J., and Sjökvist E. Structure of solid dispersions in the system polyethylene glycol-griseofulvin with additions of sodium dodecyl sulphate. Int. J. Pharm. 83 (1992) 47-52
2. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
3. Chen Y., Zhang G.G., Neilly J., Marsh K., Mawhinney D., and Sanzgiri Y.D. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int. J. Pharm. 286 (2004) 69-80
4. Corrigan O.I. Mechanims of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11 (1985) 697-724
5. Craig D.Q.M. Polyethylene glycols and drug release. Drug Dev. Ind. Pharm. 16 (1990) 2501-2526
6. Craig D.Q.M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231 (2002) 131-144
7. Curatolo W. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. Pharm. Sci. Tech. Today 1 (1998) 387-393
8. Gibaldi M., and Feldman S. Establishment of sink conditions in dissolution rate determinations. J. Pharm. Sci. 56 (1967) 1238-1242
9. Granero G.E., Ramachandran C., and Amidon G.L. Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev. Ind. Pharm. 31 (2005) 917-922
10. Hancock B.C., and Parks M. What is the true solubility advantage for amorphous pharmaceuticals?. Pharm Res. 17 (2000) 397-404
11. Huang L.F., and Tong W.Q. Impact of solid state properties on developability assessment of drug candidates. Adv. Drug Deliv. Rev. 56 (2004) 321-334
12. Keck C.M., and Muller R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm. 62 (2006) 3-16
13. Law D., Wang W., Schmitt E.A., Qiu Y., Krill S.L., and Fort J.J. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J. Pharm. Sci. 92 (2003) 505-515
14. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
15. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (2001) 3-26
16. Lobenberg R., and Amidon G.L. Modern bioavailability, bioequivalence and biopharmaceutics classification system new scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm 50 (2000) 3-12
17. Mithani S.D., Bakatselou V., TenHoor C.N., and Dressman J.B. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm. Res. 13 (1996) 163-167
18. Morris K.R., Knipp G.T., and Serajuddin A.T. Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. J. Pharm. Sci. 81 (1992) 1185-1188
19. Mura P., Faucci M.T., Manderioli A., Bramanti G., and Parrini P. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev. Ind. Pharm. 25 (1999) 257-264
20. Mura P., Moyano J.R., Gonzalez-Rodriguez M.L., Rabasco-Alvarez A.M., Cirri M., and Maestrelli F. Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev. Ind. Pharm. 31 (2005) 425-434
21. Najib N.M., Suleiman M., and Malakh A. Characteristics of the in vitro release of ibuprofen from polyvinylpyrrolidone solid dispersions. Int. J. Pharm. 32 (1986) 229-236
22. Okonogi S., and Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSci. Tech. 7 (2006) E52
23. Pan R.N., Chen J.H., and Chen R.R. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems. Drug Dev. Ind. Pharm. 26 (2000) 989-994
24. Rodriguez-Spong B., Price C.P., Jayasankar A., Matzger A.J., and Rodriguez-Hornedo N. General principles of pharmaceutical solid polymorphism: a supramolecular perspective. Adv. Drug Deliv. Rev. 56 (2004) 241-274
25. Scott T.A.J., and Melvin E.H. Determination of dextran with Anthrone. Anal. Chem. 25 (1953) 1656-1661
26. Sheu M.-T., Yeh C.-M., and Sokoloski T.D. Characterization and dissolution of fenofibrate solid dispersion systems. Int. J. Pharm. 103 (1994) 137-146
27. Sjökvist E., Nyström C., and Alden M. Physicochemical aspects of drug release XIII. The effect of sodium dodecyl sulphate additions on the structure and dissolution of a drug in solid dispersions. Int. J. Pharm. 69 (1991) 53-62
28. Sjökvist E., Nystrom C., Alden M., and Caram-Lelham N. Physicochemical aspects of drug release XIV. The effects of some ionic and non-ionic surfactants on properties of a sparingly soluble drug in solid dispersions. Int. J. Pharm. 79 (1992) 123-133
29. van Drooge D.J., Hinrichs W.L.J., and Frijlink H.W. Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent. J. Pharm. Sci. 93 (2004) 713-725
30. van Drooge D.J., Hinrichs W.L.J., and Frijlink H.W. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J. Control. Release 97 (2004) 441-452
31. van Drooge D.J., Hinrichs W.L.J., Wegman K.A.M., Visser M.R., Eissens A.C., and Frijlink H.W. Solid dispersions based on inulin for the stabilisation and formulation of Δ9-tetrahydrocannabinol. Eur. J. Pharm. Sci. 21 (2004) 511-518
32. Weintraub H., and Gibaldi M. Physiologic surface-active agents and drug absorption IV: effect of pre-micallar concentrations of surfactant on dissolution rate. J. Pharm. Sci. 58 (1969) 1368-1372
33. Wulff M., Alden M., and Craig D.Q.M. An investigation into the critical surfactant concentration for solid solubility of hydrophobic drug in different polyethylene glycols. Int. J. Pharm. 142 (1996) 189-198